Indication

Argininosuccinate lyase deficiency

Argininosuccinate lyase deficiency, also known as argininosuccinic aciduria, is an autosomal recessive urea cycle disorder caused by pathogenic variants in the *ASL* gene. Read more about Argininosuccinate lyase deficiency

12 drugs 12 manufacturers

Advertisement

Drugs that treat it

Common Argininosuccinate lyase deficiency therapies.

Showing 1–9 of 12 drugs

Filter & compare in the drug finder →Opens the drug finder with Argininosuccinate lyase deficiency preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Argininosuccinate lyase deficiency.

Argininosuccinate lyase deficiency, also known as argininosuccinic aciduria, is an autosomal recessive urea cycle disorder caused by pathogenic variants in the *ASL* gene.

This enzymatic defect impairs the conversion of argininosuccinate into arginine and fumarate, disrupting nitrogen detoxification and leading to systemic accumulations of argininosuccinic acid, citrulline, and neurotoxic ammonia.

Manifesting across pediatric and adult populations, the clinical spectrum ranges from catastrophic neonatal hyperammonemic encephalopathy to late-onset disease marked by episodic hyperammonemia, developmental delay, chronic liver dysfunction or cirrhosis, neurocognitive impairment, trichorrhexis nodosa, and systemic hypertension.

Personalize your experience

Follow Argininosuccinate lyase deficiency and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it